Latest: Watch here for details of new products and services.
- About Us
- Pharmalicensing - Open Innovation for the life sciences
- Our Products
- Overview
- Partnering Search
- Company Profiling
- Partneringtools
- Reports
- Partnering Consulting
- Due Diligence
- Comparison
- Due Diligence
- Overview
- Top Applications
- Online Panel Discussions
- Request Consultation
- Case Studies
- See what others think about our service
- Newsletter
- Partnering update
- Key reports
- Subscribe
- Quick Links
- Profile now
- Register now
- Profiled companies
- Featured events
- Industry news
- PR Newswire
- Jobs
- Forums
- Contact Pharmalicensing
- Send an email
- Call us: +44 1904 520460
- Request a callback
- RSS Feeds
- Keep up to date
Pharmalicensing Ltd
is a division of
is a division of
- Companies
- Browse
Companies
The NIH supports and conducts basic, clinical, and translational medical research, and investigates the causes, treatments, and cures for both common and rare diseases. More
BPL is one of the leading suppliers of plasma derived products in the global fractionation industry. BPL is a not-for-profit organization wholly owned by the UK government More
LAWSON HEALTH RESEARCH INSTITUTE is one of Canada's largest hospital-based research institutes. More
The University of Edinburgh has an international reputation for world-class research in medicine and biotechnology. More
LBN was established in June 2000, providing the first co-ordinated approach to biotechnology in London. With over 2000 members, LBN is now one of the largest biotechnology networks in Europe. More
NorthShore University HealthSystem Research Institute More
The IRC Network Biotechnology Thematic Group's goal is to contribute to the promotion of innovation in the European Biotechnology sector through technology transfer. More
The company positions itself as a distributor for API's and hospital specialty compounds: ATU's, generic portfolio for oncology, anti-emesis, pain management as well as intensive care . More
Development of the Magnetic Plungerless Injection System More
Good Biotech Corporation (GBC) is a leading producer of industrial scale high-purity polyclonal IgY(-Fc) antibodies from duck egg yolk, offering a wide range of biotechnology applications. More
Your selection
Browse By
- Industry sector
- Animal health
- Biotech
- Diagnostic
- Drug delivery
- Medical device
- Pharmaceutical
- Therapeutic target
- Adhesion
- Anesthesia
- Bleeding
- Cosmetic surgery
- Dialysis
- Disinfectant
- Fibrosis
- General surgery
- Infection control
- Infusion
- Injection
- Intravenous
- Irrigation
- Perfusion
- Plasma expander
- Plasma substitute
- Surgery (other)
- Tissue grafting
- Transplantation
- Wound closure
- Geographic location
- Africa
- Asia
- Australia/New Zealand
- Central America
- Europe
- Near & Far East
- North America
- South America
© Copyright 1995-2008 Pharmalicensing Ltd, is a division of 
All rights reserved. Terms and Conditions | Site map | Contact us